Functional transitions and active life expectancy associated with Alzheimer disease

Hiroko H. Dodge, Changyu Shen, Rajesh Pandav, Steven T. DeKosky, Mary Ganguli

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

Context: The concept of active life expectancy, the number of years a person can expect to live without disability, is used for the first time, to our knowledge, to examine the effect of Alzheimer disease (AD) on total life expectancy with different degrees of disability. Objectives: To estimate and compare total life expectancy and average duration lived with different degrees of disability, between persons with and without AD. Design: Ten-year prospective epidemiologic study. Setting: A largely blue-collar rural community in Southwestern Pennsylvania. Participants: A population-based cohort of 1201 subjects (at the beginning of follow-up) with a mean age of 75 years. Main Outcome Measures: At age 70 and every 2 years thereafter, among persons with AD and nondemented persons, (1) the total expectancy of remaining life and (2) the duration lived with different numbers of impaired instrumental activities of daily living (IADLs), grouped as 0 to 1, 2 to 5, and 6 to 7 impairments. Results: Alzheimer disease greatly shortened the total life expectancy to a similar extent in men and women, with the most pronounced reduction among those who were younger. Besides their shorter survival, men and women with AD spent more absolute years, and also a greater proportion of their remaining lives, with 6 to 7 IADL impairments than did their nondemented age peers. Nondemented women spent more years with 2 to 5 IADL impairments than nondemented men, while women with AD spent more years with 6 to 7 IADL impairments than men with AD. Conclusion: The concept of active life expectancy adds a useful new dimension to the study of outcomes in AD.

Original languageEnglish (US)
Pages (from-to)253-259
Number of pages7
JournalArchives of Neurology
Volume60
Issue number2
DOIs
StatePublished - Feb 1 2003
Externally publishedYes

Fingerprint

Life Expectancy
Alzheimer Disease
Activities of Daily Living
Outcome Assessment (Health Care)
Alzheimer's Disease
Rural Population
Disabled Persons
Epidemiologic Studies
Prospective Studies
Survival
Impairment
Person
Population

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Functional transitions and active life expectancy associated with Alzheimer disease. / Dodge, Hiroko H.; Shen, Changyu; Pandav, Rajesh; DeKosky, Steven T.; Ganguli, Mary.

In: Archives of Neurology, Vol. 60, No. 2, 01.02.2003, p. 253-259.

Research output: Contribution to journalArticle

Dodge, HH, Shen, C, Pandav, R, DeKosky, ST & Ganguli, M 2003, 'Functional transitions and active life expectancy associated with Alzheimer disease', Archives of Neurology, vol. 60, no. 2, pp. 253-259. https://doi.org/10.1001/archneur.60.2.253
Dodge, Hiroko H. ; Shen, Changyu ; Pandav, Rajesh ; DeKosky, Steven T. ; Ganguli, Mary. / Functional transitions and active life expectancy associated with Alzheimer disease. In: Archives of Neurology. 2003 ; Vol. 60, No. 2. pp. 253-259.
@article{5956db616387405dbdefa6e9c6d4544b,
title = "Functional transitions and active life expectancy associated with Alzheimer disease",
abstract = "Context: The concept of active life expectancy, the number of years a person can expect to live without disability, is used for the first time, to our knowledge, to examine the effect of Alzheimer disease (AD) on total life expectancy with different degrees of disability. Objectives: To estimate and compare total life expectancy and average duration lived with different degrees of disability, between persons with and without AD. Design: Ten-year prospective epidemiologic study. Setting: A largely blue-collar rural community in Southwestern Pennsylvania. Participants: A population-based cohort of 1201 subjects (at the beginning of follow-up) with a mean age of 75 years. Main Outcome Measures: At age 70 and every 2 years thereafter, among persons with AD and nondemented persons, (1) the total expectancy of remaining life and (2) the duration lived with different numbers of impaired instrumental activities of daily living (IADLs), grouped as 0 to 1, 2 to 5, and 6 to 7 impairments. Results: Alzheimer disease greatly shortened the total life expectancy to a similar extent in men and women, with the most pronounced reduction among those who were younger. Besides their shorter survival, men and women with AD spent more absolute years, and also a greater proportion of their remaining lives, with 6 to 7 IADL impairments than did their nondemented age peers. Nondemented women spent more years with 2 to 5 IADL impairments than nondemented men, while women with AD spent more years with 6 to 7 IADL impairments than men with AD. Conclusion: The concept of active life expectancy adds a useful new dimension to the study of outcomes in AD.",
author = "Dodge, {Hiroko H.} and Changyu Shen and Rajesh Pandav and DeKosky, {Steven T.} and Mary Ganguli",
year = "2003",
month = "2",
day = "1",
doi = "10.1001/archneur.60.2.253",
language = "English (US)",
volume = "60",
pages = "253--259",
journal = "Archives of Neurology",
issn = "0003-9942",
publisher = "American Medical Association",
number = "2",

}

TY - JOUR

T1 - Functional transitions and active life expectancy associated with Alzheimer disease

AU - Dodge, Hiroko H.

AU - Shen, Changyu

AU - Pandav, Rajesh

AU - DeKosky, Steven T.

AU - Ganguli, Mary

PY - 2003/2/1

Y1 - 2003/2/1

N2 - Context: The concept of active life expectancy, the number of years a person can expect to live without disability, is used for the first time, to our knowledge, to examine the effect of Alzheimer disease (AD) on total life expectancy with different degrees of disability. Objectives: To estimate and compare total life expectancy and average duration lived with different degrees of disability, between persons with and without AD. Design: Ten-year prospective epidemiologic study. Setting: A largely blue-collar rural community in Southwestern Pennsylvania. Participants: A population-based cohort of 1201 subjects (at the beginning of follow-up) with a mean age of 75 years. Main Outcome Measures: At age 70 and every 2 years thereafter, among persons with AD and nondemented persons, (1) the total expectancy of remaining life and (2) the duration lived with different numbers of impaired instrumental activities of daily living (IADLs), grouped as 0 to 1, 2 to 5, and 6 to 7 impairments. Results: Alzheimer disease greatly shortened the total life expectancy to a similar extent in men and women, with the most pronounced reduction among those who were younger. Besides their shorter survival, men and women with AD spent more absolute years, and also a greater proportion of their remaining lives, with 6 to 7 IADL impairments than did their nondemented age peers. Nondemented women spent more years with 2 to 5 IADL impairments than nondemented men, while women with AD spent more years with 6 to 7 IADL impairments than men with AD. Conclusion: The concept of active life expectancy adds a useful new dimension to the study of outcomes in AD.

AB - Context: The concept of active life expectancy, the number of years a person can expect to live without disability, is used for the first time, to our knowledge, to examine the effect of Alzheimer disease (AD) on total life expectancy with different degrees of disability. Objectives: To estimate and compare total life expectancy and average duration lived with different degrees of disability, between persons with and without AD. Design: Ten-year prospective epidemiologic study. Setting: A largely blue-collar rural community in Southwestern Pennsylvania. Participants: A population-based cohort of 1201 subjects (at the beginning of follow-up) with a mean age of 75 years. Main Outcome Measures: At age 70 and every 2 years thereafter, among persons with AD and nondemented persons, (1) the total expectancy of remaining life and (2) the duration lived with different numbers of impaired instrumental activities of daily living (IADLs), grouped as 0 to 1, 2 to 5, and 6 to 7 impairments. Results: Alzheimer disease greatly shortened the total life expectancy to a similar extent in men and women, with the most pronounced reduction among those who were younger. Besides their shorter survival, men and women with AD spent more absolute years, and also a greater proportion of their remaining lives, with 6 to 7 IADL impairments than did their nondemented age peers. Nondemented women spent more years with 2 to 5 IADL impairments than nondemented men, while women with AD spent more years with 6 to 7 IADL impairments than men with AD. Conclusion: The concept of active life expectancy adds a useful new dimension to the study of outcomes in AD.

UR - http://www.scopus.com/inward/record.url?scp=0037318497&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037318497&partnerID=8YFLogxK

U2 - 10.1001/archneur.60.2.253

DO - 10.1001/archneur.60.2.253

M3 - Article

VL - 60

SP - 253

EP - 259

JO - Archives of Neurology

JF - Archives of Neurology

SN - 0003-9942

IS - 2

ER -